This report offers a global description of the arrhythmic burden, which may have important therapeutic consequences. The duration of the episodes must be included when pondering whether to introduce an antithrombotic regimen while the shortest duration justifying its introduction is ill-defined. The time of onset of the episodes may also influence the decision to introduce an antiarrhythmic regimen. Should the episodes systematically occur at night, a vagal mechanism is suspected and beta-adrenergic blockade avoided. Conversely, beta-adrenergic blockade should be strongly considered if the episodes develop systematically during exercise. Furthermore, the ventricular rate following an arrhythmic episode helps modulating a rate-slowing treatment.